A Study to Evaluate the Safety and Efficacy of Omnitrope in Adult Patients with Growth Hormone Deficiency

Trial Profile

A Study to Evaluate the Safety and Efficacy of Omnitrope in Adult Patients with Growth Hormone Deficiency

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Apr 2017

At a glance

  • Drugs Somatropin (Primary)
  • Indications Growth disorders
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms PATRO Adults
  • Most Recent Events

    • 04 Apr 2017 Interim safety results (As of December 2016; n=1121) presented at The 99th Annual Meeting of the Endocrine Society
    • 04 Feb 2017 Interim results (n=67, data cut off: Aug 2015) published in the Journal of Endocrinological Investigation
    • 22 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top